221 related articles for article (PubMed ID: 38546391)
1. Associations of PD-1 and PD-L1 gene polymorphisms with cancer risk: a meta-analysis based on 50 studies.
Yang M; Liu Y; Zheng S; Geng P; He T; Lu L; Feng Y; Jiang Q
Aging (Albany NY); 2024 Mar; 16(7):6068-6097. PubMed ID: 38546391
[TBL] [Abstract][Full Text] [Related]
2. Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population.
Xie Q; Chen Z; Xia L; Zhao Q; Yu H; Yang Z
Gene; 2018 Oct; 674():188-194. PubMed ID: 29940275
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the Possible Association between PD-1 (Rs11568821, Rs2227981, Rs2227982) and PD-L1 (Rs4143815, Rs2890658) Polymorphisms and Susceptibility to Breast Cancer in a Sample of Southeast Iranian Women.
Karami S; Sattarifard H; Kiumarsi M; Sarabandi S; Taheri M; Hashemi M; Bahari G; Ghavami S
Asian Pac J Cancer Prev; 2020 Oct; 21(10):3115-3123. PubMed ID: 33112575
[TBL] [Abstract][Full Text] [Related]
4. Relationship of Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PD-L1) Polymorphisms with Overall Cancer Susceptibility: An Updated Meta-Analysis of 28 Studies with 60 612 Subjects.
Zhang W; Song Y; Zhang X
Med Sci Monit; 2021 May; 27():e932146. PubMed ID: 34024901
[TBL] [Abstract][Full Text] [Related]
5. Common inherited variants of PDCD1, CD274 and HAVCR2 genes differentially modulate the risk and prognosis of adenocarcinoma and squamous cell carcinoma.
Moksud N; Wagner M; Pawełczyk K; Porębska I; Muszczyńska-Bernhard B; Kowal A; Wiśniewski A; Kosacka M; Kończak J; Karpiński P; Frydryk D; Andrzejczak A; Karabon L; Kuśnierczyk P; Jasek M
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6381-6390. PubMed ID: 36759392
[TBL] [Abstract][Full Text] [Related]
6. Programmed death-ligand 1 (PD-L1) polymorphisms as predictive biomarkers for the development of liver cirrhosis and hepatocellular carcinoma in HCV Egyptian patients.
Hassan M; Attia MS; Ali-Eldin Z; El Attar G; Elzallat M; Saad HHK; Isaac A
Tumour Virus Res; 2022 Dec; 14():200249. PubMed ID: 36265835
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of the programmed death-ligand 1 gene is associated with its protein expression and prognosis in gastric cancer.
Wu Y; Zhao T; Jia Z; Cao D; Cao X; Pan Y; Zhao D; Zhang B; Jiang J
J Gastroenterol Hepatol; 2019 Jul; 34(7):1201-1207. PubMed ID: 30353572
[TBL] [Abstract][Full Text] [Related]
8. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH
Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662
[TBL] [Abstract][Full Text] [Related]
9. Association of PD-L1 gene rs4143815 C>G polymorphism and human cancer susceptibility: A systematic review and meta-analysis.
Zou J; Wu D; Li T; Wang X; Liu Y; Tan S
Pathol Res Pract; 2019 Feb; 215(2):229-234. PubMed ID: 30552042
[TBL] [Abstract][Full Text] [Related]
10. The blockage signal for PD-L1/CD274 gene variants and their potential impact on lung carcinoma susceptibility.
Sakran MI; Alalawy AI; Alharbi AA; El-Hefnawy ME; Alzahrani SM; Alfuraydi A; Alzuaibr FM; Zidan NS; Elsaid AM; Toraih EA; Elshazli RM
Int Immunopharmacol; 2023 Dec; 125(Pt A):111180. PubMed ID: 37939515
[TBL] [Abstract][Full Text] [Related]
11. Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer.
Tan D; Sheng L; Yi QH
Cancer Biomark; 2018 Feb; 21(2):287-297. PubMed ID: 29171986
[TBL] [Abstract][Full Text] [Related]
12. Programmed death-1 ligand-1 gene rs2890658 polymorphism associated with the risk of esophageal squamous cell carcinoma in smokers.
Zhou RM; Li Y; Liu JH; Wang N; Huang X; Cao SR; Shan BE
Cancer Biomark; 2017 Dec; 21(1):65-71. PubMed ID: 29060926
[TBL] [Abstract][Full Text] [Related]
13. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 rs2890658 Polymorphism Increases Risk for Non-Small-Cell Lung Cancer in Northern China Population Based on Experimental Data and Meta-Analysis.
Wang G; Dong Y; Yang Y; Zhang W; Liu N; Wei Y
Contrast Media Mol Imaging; 2022; 2022():8433489. PubMed ID: 35992543
[TBL] [Abstract][Full Text] [Related]
15. PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors.
Minari R; Bonatti F; Mazzaschi G; Dodi A; Facchinetti F; Gelsomino F; Cinquegrani G; Squadrilli A; Bordi P; Buti S; Bersanelli M; Leonetti A; Cosenza A; Ferri L; Rapacchi E; Quaini F; Ardizzoni A; Tiseo M
Tumori; 2022 Feb; 108(1):47-55. PubMed ID: 34002648
[TBL] [Abstract][Full Text] [Related]
16. Elevated programmed cell death-1 protein/ligand (PD-1/PD-L1) and variants are associated with susceptibility to multiple myeloma: a case-control study in the Chinese cohort.
Yang J; Meng L; Yang Y; Gao H; Jiang H
Nucleosides Nucleotides Nucleic Acids; 2024; 43(3):230-248. PubMed ID: 37688463
[TBL] [Abstract][Full Text] [Related]
17. SNP-SNP Interaction in Genes Encoding PD-1/PD-L1 Axis as a Potential Risk Factor for Clear Cell Renal Cell Carcinoma.
Wagner M; Tupikowski K; Jasek M; Tomkiewicz A; Witkowicz A; Ptaszkowski K; Karpinski P; Zdrojowy R; Halon A; Karabon L
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33255938
[TBL] [Abstract][Full Text] [Related]
18. Relationship of PD-1 (PDCD1) and PD-L1 (CD274) Single Nucleotide Polymorphisms with Polycystic Ovary Syndrome.
Han R; Gong X; Zhu Y; Liu X; Xia Y; Huang Y; Zhang M; Zhang Y; La X; Ding J
Biomed Res Int; 2021; 2021():9596358. PubMed ID: 33521133
[TBL] [Abstract][Full Text] [Related]
19. A polymorphism in the promoter region of PD-L1 serves as a binding-site for SP1 and is associated with PD-L1 overexpression and increased occurrence of gastric cancer.
Tao LH; Zhou XR; Li FC; Chen Q; Meng FY; Mao Y; Li R; Hua D; Zhang HJ; Wang WP; Chen WC
Cancer Immunol Immunother; 2017 Mar; 66(3):309-318. PubMed ID: 27889799
[TBL] [Abstract][Full Text] [Related]
20. Association between
Hashemi M; Karami S; Sarabandi S; Moazeni-Roodi A; Małecki A; Ghavami S; Wiechec E
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31405171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]